Selpercatinib
Drug timelines are a Plus or Pro feature.
15 regulatory and trial events tracked for Selpercatinib, covering 2024-06-20 to 2026-03-04. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Selpercatinib After Surgery or Radiation in Participants With Non-Small Cell Lung Cancer (NSCLC) [Phase 3]